Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes

Figure 6

Correlation between genes and immune cells in the risk model. Correlation of (a) KIAA1429, (b) HAMP, (c) AQP9, (d) CCL13, and (e) CCL21 with tumor purity and the levels of B cells, CD8 T cells, CD4 T cells, macrophages, neutrophils, and dendritic cells.

(a)

(b)

(c)

(d)

(e)